Human Papillomavirus Vaccine Recombinant Quadrivalent

    November 2009 in “ Reactions Weekly
    &NA;
    Image of study
    TLDR Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.
    In a 2009 report, two women experienced patchy alopecia following mesotherapy treatments for androgenic alopecia. The first, a 32-year-old, received injections containing mesoglycan and developed an erythematous patch of alopecia, paraesthesias, trichodynia, and hair loss, with a marked decrease in hair density and almost no terminal anagen hair follicles on biopsy. After 3 months, she had residual scarring alopecia. The second, a 22-year-old, had four sessions with a homeopathic solution and developed erythematous patches of alopecia. Biopsy showed a prominent decrease in hair density, increased catagen follicles and telogen germinal units, and dilated infundibular ostia. She experienced complete hair regrowth after 7 months. The cause of hair loss was unclear, and no previous reports of alopecia associated with mesoglycan were found in medical databases.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 579 results

    Similar Research

    5 / 1000+ results
      Alopecia Secondary to Mesotherapy

      research Alopecia Secondary to Mesotherapy

      49 citations , July 2009 in “Journal of the American Academy of Dermatology”
      Some people experienced hair loss after mesotherapy treatments for hair loss.
      Alopecia Areata: An Update

      research Alopecia Areata: An Update

      67 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.
      Mesotherapy: Myth and Reality

      research Mesotherapy: Myth and Reality

      3 citations , April 2011 in “Expert Review of Dermatology”
      Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.